Graft-Versus-Host Disease: Immunobiological Aspects

  • P. J. Tutschka
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 28)

Abstract

Graft-versus-host disease continues to be a major problem in clinical allogeneic bone marrow transplantation, Despite great efforts to describe the disease clinically, histopathologically and immunologically we are far from understanding the immunobiology of graft-versus-host disease and transplantation tolerance, preventing us from developing rational clinical strategies to overcome this stumbling block.

Keywords

Leukemia Fractionation Polypeptide Nylon Cyclosporin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brent L, Brooks CG, Medawar PB, Simpson E (1976) Br Med Bull 32 (2): 101PubMedGoogle Scholar
  2. 2.
    Santos GW, Elfenbein GJ, Sharkis S, Tutschka PJ (1980) In: Gelfand EW, Dosch HM (eds) Advances in pediatric research 1: Biological basis of immunodeficiency. Raven, New York p 293Google Scholar
  3. 3.
    Tutschka PJ (1982) In: Slavin G, (ed) Organ transplantation – present state, future goals. Elsevier/North Holland, AmsterdamGoogle Scholar
  4. 4.
    Tutschka PJ, Chabner B (1980) Biology of bone marrow transplantation: 291Google Scholar
  5. 5.
    Santos GW, Tutschka PJ, Elfenbein GJ (1979) In: Hickey RC, (ed) Current problems in cancer. Yearbook Medical Publishers, Chicago 4, p 3Google Scholar
  6. 6.
    Tutschka PJ, Bortin MM (1981) Transplant Proc 13 (No.1): 1267Google Scholar
  7. 7.
    Grebe SC, Streilein JW (1976) Adv Immunol 22: 119PubMedCrossRefGoogle Scholar
  8. 8.
    Elkins WL (1978) Transplant Proc 10 (1): 15PubMedGoogle Scholar
  9. 9.
    Tutschka PJ, Hess AD, Beschorner WE, Santos GW (1981) Transplantation 32 (No. 3):203PubMedCrossRefGoogle Scholar
  10. 10.
    Simonson M (1957) Acta Pathol Microbiol Scand 40:480Google Scholar
  11. 11.
    Billingham RE (1966) Harvey Lect Ser 62:21Google Scholar
  12. 12.
    Elkins WL (1979) In: Stuart FP, Fitch FW (eds) Immunological tolerance and enhancement. MTP Press, p 1Google Scholar
  13. 13.
    Seemayer TA (1979) Respect Pediatr Pathol 5:93–136Google Scholar
  14. 14.
    Tutschka PJ, Farmer E, Beschorner WE, Mundorf L, Harrison D, Santos GW (1981) Exp Hematol 9 (Suppl 9): 126Google Scholar
  15. 15.
    Tutschka PJ, Santos GW (1975) Transplantation 20: 101PubMedCrossRefGoogle Scholar
  16. 16.
    Storb R, Rudolph RH, Kolb HY (1973) Transplantation 15:92PubMedCrossRefGoogle Scholar
  17. 17.
    Klein Y (1976) Transplant Proc 8 (3):335PubMedGoogle Scholar
  18. 18.
    Tutschka PJ (1981) Exp Hematol 9 (Suppl 9): 173Google Scholar
  19. 19.
    Rappeport J, Mihm M, Reinherz E et al. (1979) Lancet 2: 717PubMedCrossRefGoogle Scholar
  20. 20.
    Parkman R et al. (1979) N Eng J Med 301:556Google Scholar
  21. 21.
    Gluckman E, Devergie H, Sohur J et al. (1980) Lancet 253Google Scholar
  22. 22.
    Beschorner WE, Tutschka PJ, Santos GW (1983) Chronic graft-versus-host disease in the rat radiation chimera. III. Immunology and immunopathology in rapidly induced models. Transplantation (in press)Google Scholar
  23. 23.
    Pollard M, Chanig CF, Srivastava KK (1976) Transplant Proc 8 (4):533PubMedGoogle Scholar
  24. 24.
    Van Bekkum DW, Roodenburg J, Heidt PJ et al. (1979) J Nat Canc JustGoogle Scholar
  25. 25.
    Elfenbein GJ, Saral R (1980) In: Allen JC (ed) Infection and the compromised host: Clinical correlations and therapeutic applications. 2nd edn. Williams and Wilkins Co., Baltimore, p 157Google Scholar
  26. 26.
    Neiman PE, Reeves WC, Ray GJ (1977) Infect Dis 136Google Scholar
  27. 27.
    Haskova V, Gasnova E, Hajna I (1973) Biol (Praka) 19:261Google Scholar
  28. 28.
    Singal DP, Rawls WE (1980) Transplantation 29:500PubMedCrossRefGoogle Scholar
  29. 29.
    Zschiesche W, Vargin VV (1976) Acta Virol 20:445PubMedGoogle Scholar
  30. 30.
    Tutschka PJ, Schwerdtfeger R, Slavin R, Santos G (1977) In: Baum SJ, Ledney GD (eds) Experimental hematology today. Springer Berlin Heidelberg New York, p 191Google Scholar
  31. 31.
    Tutschka PJ, Beschorner WE, Santos GW (1979) Transplant Proc 112 (No. 1): 882Google Scholar
  32. 32.
    Tutschka PJ (1979) In: Thierfelder S (ed) Immunforschung fur Klinik und Labor. Germany, p 107Google Scholar
  33. 33.
    Tutschka PJ, Hess AD, Beschorner WE, Santos GW (1981) Transplantation 32 (No. 3):203PubMedCrossRefGoogle Scholar
  34. 34.
    Tutschka PJ, Ki PF, Beschorner WE, Hess AD, Santos GW (1981) Transplantation 32 (No. 4):321PubMedCrossRefGoogle Scholar
  35. 35.
    Cohen JR, Globerson H, Feldman MJ (1971) J Exp Med 133:834PubMedCrossRefGoogle Scholar
  36. 36.
    Parkman R, Rosen FS (1976) J Exp Med 144: 1520PubMedCrossRefGoogle Scholar
  37. 37.
    L’Age-Stehr J, Diamantstein T (1978) Eur J Immunol 8:620PubMedCrossRefGoogle Scholar
  38. 38.
    Gozes Y, Umiel T, Meshorer A, Trainin NJ (1978) J Immunol 2199Google Scholar
  39. 39.
    Belanger R, Tutschka PJ, Beschorner WE, Santos GW (1983) Acute graft-versus-host disease in recipients of syngeneic bone marrow. Exp Hematol (in press)Google Scholar
  40. 40.
    Tutschka PJ, Belanger R, Hess AD, Beschorner WE, Santos GW (1983) Suppressor cells in transplantation tolerance to self and nonself. Transplant Proc (in press)Google Scholar
  41. 41.
    Beschorner WE, Tutschka PJ, Santos GW (1982) Transplantation 33 (No. 4):393–397PubMedCrossRefGoogle Scholar
  42. 42.
    Beschorner WE, Tutschka PJ (1980) Inter Assoc Pathol Lab Invest 42: 102Google Scholar
  43. 43.
    Beschorner WE, Hess AD, Tutschka PJ (1980) Chronic graft-versus-host disease in the rat radiation chimera: thymus and lymphoid tissue morphology. VIII International Congress of the Transplantation Society, Boston 1980Google Scholar
  44. 44.
    Beschorner WE, Tutschka PJ, Santos GW (1981) Fed Proc 140: 1561Google Scholar
  45. 45.
    Tutschka PJ, Teasdall R, Beschorner WE, Santos GW (1982) Chronic graft-versus-host disease in the rat radiation chimera. II. Immunologic evaluation in long-term chimeras. Transplantation 34 (No. 5):289PubMedCrossRefGoogle Scholar
  46. 46.
    Tsoi MS, Storb R, Dobbs S, Santos E, Thomas ED (1981) Transplant Proc 13 (1):237–240PubMedGoogle Scholar
  47. 47.
    Hess AD, Tutschka PJ, Saral R, Santos GW (1982) Exp Hematol 10 (Suppl 11):64Google Scholar
  48. 48.
    Hess AD, Tutschka PJ, Santos GW (1982) The effect of cyclosporin A on T-lymphocyte subpopulations. In: White DJG (ed) International symposium on cyclosporin A. Elsevier/North Holland, Amsterdam pp 209–231Google Scholar
  49. 49.
    Tutschka PJ, Hess AD, Beschorner WE, Santos GW (1982) Cyclosporin A in allogeneic bone marrow transplantation. Preclinical and clinical studies. In: White DJG (ed) International symposium on cyclosporin A. Elsevier/North Holland, Amsterdam pp 519–538Google Scholar
  50. 50.
    Tutschka PJ, Beschorner WE, Allision AC, Burns WH, Santos GW (1979) Nature 280: 148–151PubMedCrossRefGoogle Scholar
  51. 51.
    Tutschka PJ, Beschorner WE, Hess AD, Santos WE (1983) Cyclosporin A to prevent grft-versus-host disease. A pilot study in 22 patients receiving allogeneic marrow transplant. Blood (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • P. J. Tutschka

There are no affiliations available

Personalised recommendations